Prudential Financial’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$346K Sell
145,900
-24,290
-14% -$84.1K ﹤0.01% 1982
2025
Q4
$882K Buy
170,190
+93,590
+122% +$453K ﹤0.01% 1637
2025
Q3
$323K Sell
76,600
-114,600
-60% -$533K ﹤0.01% 2083
2025
Q2
$700K Sell
191,200
-38,860
-17% -$145K ﹤0.01% 1812
2025
Q1
$994K Sell
230,060
-7,660
-3% -$30.9K ﹤0.01% 1571
2024
Q4
$761K Buy
237,720
+114,500
+93% +$384K ﹤0.01% 1683
2024
Q3
$352K Buy
123,220
+2,800
+2% +$7.85K ﹤0.01% 2356
2024
Q2
$337K Buy
120,420
+1,800
+2% +$4.83K ﹤0.01% 2314
2024
Q1
$337K Buy
118,620
+76,800
+184% +$261K ﹤0.01% 2299
2023
Q4
$171K Sell
41,820
-32,000
-43% -$89.6K ﹤0.01% 2464
2023
Q3
$235K Sell
73,820
-31,900
-30% -$101K ﹤0.01% 2339
2023
Q2
$351K Sell
105,720
-286,850
-73% -$848K ﹤0.01% 2248
2023
Q1
$836K Sell
392,570
-104,635
-21% -$259K ﹤0.01% 1828
2022
Q4
$1.34M Buy
497,205
+23,300
+5% +$68K ﹤0.01% 1544
2022
Q3
$1.54M Buy
473,905
+27,700
+6% +$125K ﹤0.01% 1505
2022
Q2
$2.18M Sell
446,205
-79,909
-15% -$492K ﹤0.01% 1344
2022
Q1
$4.01M Sell
526,114
-59,366
-10% -$459K 0.01% 1090
2021
Q4
$5.41M Sell
585,480
-4,834
-0.8% -$51.3K 0.01% 985
2021
Q3
$8.41M Sell
590,314
-3,527
-0.6% -$54.8K 0.01% 784
2021
Q2
$9.87M Buy
593,841
+91,421
+18% +$1.7M 0.01% 766
2021
Q1
$9.15M Buy
+502,420
New +$6.81M 0.01% 801

Other funds holding ORGO

Prudential Financial's ORGO Position: Q1 2026 in Review

Prudential Financial reduced its Organogenesis Holdings (ORGO) stake by 14% in Q1 2026, selling an estimated $84.1K and leaving 145,900 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

Prudential Financial first reported a position in ORGO in Q1 2021 and has held it in 21 quarters since. The position peaked at $9.87M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Prudential Financial held 145,900 shares of Organogenesis Holdings worth $346K as of Q1 2026.
  • Prudential Financial sold 24,290 Organogenesis Holdings shares in Q1 2026, an estimated $84.1K.
  • Organogenesis Holdings made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1982 holding.
  • Prudential Financial first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 21 quarters since.
  • Prudential Financial's Organogenesis Holdings position peaked at $9.87M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.